MARK2 and cancer: Next, we investigated whether pharmacological inhibition could phenocopy above sensitization findings induced by siRNA silencing and selected PDPK1 as a major regulator for the activation of AGC kinases (serine/threonine kinases of the protein kinase A, G, and C family) and canonical AKT signaling in cancer cells.